BELFB vs RARE · P/E 31, $1.28B cap vs rev $350.0M
Bel Fuse B Inc (BELFB) versus Ultragenyx (RARE) — a side-by-side from cached financials, not a winner call.
Bel Fuse B Inc (BELFB) is a electronic components company listed on US.
Ultragenyx (RARE) is a biotechnology company listed on US.
BELFB does not have a complete income-statement cache yet.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
BELFB currently screens at market cap $1.28B and trailing P/E 30.9. RARE currently screens at market cap $2.79B.
Not investment advice. Open the BELFB and RARE stock pages for the full models.
Not investment advice.